Cargando…
Two grams of sarcosine in schizophrenia – is it too much? A potential role of glutamate-serotonin interaction
Glutamate is the main excitatory neurotransmitter in the central nervous system. Dysfunction of the glutamatergic system plays an important role in the pathogenesis of schizophrenia. Therefore, glutamatergic agents such as N-methyl-D-aspartate receptor co-agonists (ie, glycine, D-cycloserine) and gl...
Autores principales: | Strzelecki, Dominik, Szyburska, Justyna, Rabe-Jabłońska, Jolanta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921092/ https://www.ncbi.nlm.nih.gov/pubmed/24523591 http://dx.doi.org/10.2147/NDT.S54024 |
Ejemplares similares
-
Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study
por: Strzelecki, Dominik, et al.
Publicado: (2015) -
MMP-9 Serum Levels in Schizophrenic Patients during Treatment Augmentation with Sarcosine (Results of the PULSAR Study)
por: Strzelecki, Dominik, et al.
Publicado: (2016) -
Sarcosine May Induce EGF Production or Inhibit the Decline in EGF Concentrations in Patients with Chronic Schizophrenia (Results of the PULSAR Study)
por: Pawlak, Agnieszka, et al.
Publicado: (2023) -
Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex
por: Strzelecki, Dominik, et al.
Publicado: (2015) -
Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia
por: Strzelecki, Dominik, et al.
Publicado: (2015)